Earnings Call · Q2 FY2021·2021-08-03

Q2 21EPS 0.00%·Rev n/aQ1 21EPS -50.00%·Rev n/aQ4 20EPS 0.00%·Rev n/aQ3 20EPS +22.22%·Rev n/a⚠ consensus missing

Niagen Bioscience, Inc. NAGE

Brianna Gerber — Investor Relations

Rob Fried — Chief Executive Officer

Frank Jaksch — Founder and Executive Chairman

Kevin Farr — Chief Financial Officer

−2.1%1d on move date−2.9% vs SPY3d−2.1%5d−2.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NAGE calls or request research access.

More NAGE calls Browse calls Request research access